Scarica l'app Stockscreener
2.39
1.65%
-0.04
Dopo l'orario di chiusura:
2.42
0.03
+1.26%
Precedente Chiudi:
$2.43
Aprire:
$2.45
Volume 24 ore:
299.99K
Relative Volume:
1.00
Capitalizzazione di mercato:
$251.46M
Reddito:
$7.05M
Utile/perdita netta:
$-30.43M
Rapporto P/E:
-6.3094
EPS:
-0.3788
Flusso di cassa netto:
$21.84M
1 W Prestazione:
+9.13%
1M Prestazione:
+15.46%
6M Prestazione:
+18.32%
1 anno Prestazione:
+26.12%
Intervallo 1D:
$2.28
$2.4896
Intervallo di 1 settimana:
$2.13
$2.49
Portata 52W:
$1.07
$4.62
Proqr Therapeutics N V Stock (PRQR) Company Profile
Nome
Proqr Therapeutics N V
Settore
Industria
Telefono
-
Indirizzo
-
Confronta PRQR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRQR
Proqr Therapeutics N V
|
2.39 | 241.24M | 7.05M | -30.43M | 21.84M | -0.3788 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Proqr Therapeutics N V Stock (PRQR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-29 | Ripresa | Cantor Fitzgerald | Overweight |
| 2025-04-29 | Iniziato | Evercore ISI | Outperform |
| 2025-03-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-01-10 | Iniziato | Oppenheimer | Outperform |
| 2024-10-29 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-11-08 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2023-03-30 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2022-12-22 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2022-02-14 | Downgrade | Citigroup | Buy → Neutral |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2022-02-11 | Downgrade | Stifel | Buy → Hold |
| 2022-02-01 | Iniziato | Raymond James | Strong Buy |
| 2021-05-03 | Iniziato | Stifel | Buy |
| 2021-03-25 | Reiterato | Citigroup | Buy |
| 2020-11-03 | Ripresa | Cantor Fitzgerald | Overweight |
| 2019-03-12 | Reiterato | Chardan Capital Markets | Buy |
| 2018-12-19 | Iniziato | RBC Capital Mkts | Outperform |
| 2018-11-15 | Iniziato | Citigroup | Buy |
| 2018-09-19 | Iniziato | Evercore ISI | Outperform |
| 2017-09-26 | Reiterato | JMP Securities | Mkt Outperform |
| 2016-06-20 | Iniziato | Chardan Capital Markets | Neutral |
| 2014-10-15 | Iniziato | Deutsche Bank | Buy |
| 2014-10-13 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Proqr Therapeutics N V Borsa (PRQR) Ultime notizie
Will ProQR Therapeutics N.V. benefit from current market trendsJuly 2025 Market Mood & Free Technical Confirmation Trade Alerts - khodrobank.com
Can technical indicators confirm ProQR Therapeutics N.V.’s reversalMarket Trend Summary & High Accuracy Investment Signals - Newser
What high frequency data says about ProQR Therapeutics N.V.2025 Trade Ideas & Technical Buy Zone Confirmations - Newser
Can trapped investors hope for a rebound in ProQR Therapeutics N.V.July 2025 Breakouts & AI Optimized Trade Strategies - Newser
What Fibonacci levels say about ProQR Therapeutics N.V. reboundJuly 2025 Snapshot & Low Drawdown Momentum Trade Ideas - Newser
How hedge fund analytics apply to ProQR Therapeutics N.V. stockJuly 2025 Analyst Calls & Expert Approved Momentum Ideas - Newser
Is it too late to sell ProQR Therapeutics N.V.2025 Trade Ideas & Fast Gain Stock Tips - Newser
ProQR Therapeutics N.V. stock trend outlook and recovery pathQuarterly Profit Review & Technical Pattern Based Signals - Newser
ProQR Therapeutics N.V. recovery potential after sell off2025 Breakouts & Breakdowns & Reliable Volume Spike Trade Alerts - Newser
What are ProQR Therapeutics N.V.’s recent SEC filings showingIPO Watch & Verified Chart Pattern Trade Signals - khodrobank.com
Is ProQR Therapeutics N.V. meeting your algorithmic filter criteria2025 Market Overview & AI Forecast for Swing Trade Picks - Newser
Can ProQR Therapeutics N.V. recover in the next quarterJuly 2025 Trends & Low Risk Growth Stock Ideas - Newser
Buy Signal: What are ProQR Therapeutics N.V.’s recent SEC filings showingM&A Rumor & Growth Focused Investment Plans - khodrobank.com
How cyclical is ProQR Therapeutics N.V.’s revenue streamGlobal Markets & Verified Entry Point Detection - khodrobank.com
Can ProQR Therapeutics N.V. be recession proofJuly 2025 Update & High Accuracy Trade Signal Alerts - khodrobank.com
Is ProQR Therapeutics N.V. benefiting from innovation trendsAnalyst Downgrade & Precise Entry and Exit Recommendations - khodrobank.com
Can ProQR Therapeutics N.V. reach resistance levels soon2025 Market Outlook & Growth-Oriented Investment Plans - khodrobank.com
Building trade automation scripts for ProQR Therapeutics N.V.2025 Market Trends & Low Drawdown Investment Ideas - Newser
What is the earnings history of ProQR Therapeutics N.V.July 2025 Rallies & Daily Profit Focused Stock Screening - khodrobank.com
Research Analysts Issue Forecasts for PRQR FY2025 Earnings - MarketBeat
Is ProQR Therapeutics N.V. building a consolidation baseMarket Growth Report & Daily Market Momentum Tracking - Newser
What to expect from ProQR Therapeutics N.V. in the next 30 daysJuly 2025 Gainers & Safe Entry Trade Signal Reports - Newser
Is ProQR Therapeutics N.V. a potential multi baggerInsider Selling & High Yield Equity Trading Tips - khodrobank.com
Will ProQR Therapeutics N.V. price bounce be sustainable2025 Fundamental Recap & Accurate Entry/Exit Alerts - Newser
Can ProQR Therapeutics N.V. generate free cash flowJuly 2025 Weekly Recap & Real-Time Buy Signal Notifications - khodrobank.com
What’s the RSI of ProQR Therapeutics N.V. stockTrade Exit Summary & High Conviction Buy Zone Picks - khodrobank.com
Is ProQR Therapeutics N.V. likely to announce a buybackGlobal Markets & Entry Point Strategy Guides - khodrobank.com
Sector ETF performance correlation with ProQR Therapeutics N.V.July 2025 Recap & High Accuracy Investment Entry Signals - Newser
Affinity Asset Advisors LLC Boosts Stock Position in ProQR Therapeutics N.V. $PRQR - MarketBeat
Is now a turning point for ProQR Therapeutics N.V.July 2025 Gainers & Consistent Income Trade Ideas - Newser
Measuring ProQR Therapeutics N.V.’s beta against major indicesPortfolio Update Summary & Safe Capital Growth Tips - Newser
How high can ProQR Therapeutics N.V. stock goJuly 2025 Decliners & Short-Term Trading Opportunity Alerts - Newser
Momentum divergence signals in ProQR Therapeutics N.V. chart2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - Newser
Chart based analysis of ProQR Therapeutics N.V. trendsPortfolio Risk Summary & Real-Time Chart Pattern Alerts - Newser
How to build a dashboard for ProQR Therapeutics N.V. stock2025 Analyst Calls & Consistent Profit Trading Strategies - Newser
What data driven models say about ProQR Therapeutics N.V.’s futureJuly 2025 Institutional & Fast Entry and Exit Trade Plans - Newser
How to track smart money flows in ProQR Therapeutics N.V.Oil Prices & Detailed Earnings Play Strategies - Newser
Proqr Therapeutics N V Azioni (PRQR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):